METHODS FOR REDUCING THE RISK OF AN ADVERSE TERIFLUNOMIDE AND ROSUVASTATIN INTERACTION IN MULTIPLE SCLEROSIS PATIENTS

• 收藏
• 分享

专利权人:

Pierre-Francois CLOT;Sandrine TURPAULT;Dietmar WEITZ;Francoise MENGUY-VACHERON

发明人:

Dietmar WEITZ,Francoise MENGUY-VACHERON,Pierre-Francois CLOT,Sandrine TURPAULT

申请号：

US14172082

公开号：

US20140256758A1

申请日:

2014.02.04

申请国别(地区):

US

年份:

2014

代理人:

摘要：

This invention relates to a method for managing the risk of an adverse interaction between teriflunomide and a substrate of breast cancer resistance protein (BCRP) and/or organic anion transporting polypeptide B1 and B3 (OATP1B1/B3).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/